Additional file 3: of Integrative omics analyses broaden treatment targets in human cancer
- Sohini Sengupta (5567477)
- Sam Sun (5567480)
- Kuan-lin Huang (473523)
- Clara Oh (5567483)
- Matthew Bailey (3427394)
- Rajees Varghese (5567486)
- Matthew Wyczalkowski (5567489)
- Jie Ning (3420689)
- Piyush Tripathi (5567492)
- Joshua McMichael (3568127)
- Kimberly Johnson (5567495)
- Cyriac Kandoth (746224)
- John Welch (3281673)
- Cynthia Ma (4609264)
- Michael Wendl (5567498)
- Samuel Payne (5369300)
- David FenyĂś (3399305)
- Reid Townsend (5567504)
- John Dipersio (5567507)
- Feng Chen (25347)
- Li Ding (16240)
Publication date
July 2018
DOIAbstract
Figure S1. Fusions in the TCGA cohort. Figure S2. Druggable protein expression outliers using mass spectrometry. Figure S3. Co-occurring druggable mutations represent opportunities for combinational and alternative therapy. Figure S4. Druggability and Demographics. Figure S5. Potential Druggability by Cancer Type. (PDF 514Â KB) (PDF 501 kb
.jpg%3Fwidth%3D300&w=3840&q=75)
Add to ORKG